Recurrent Solid Tumor: Clinical Trials

1 trial for Recurrent Solid Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Recurrent Solid Tumor: new trials by email Literature Review of Recurrent Solid Tumor trials Research Report on Recurrent Solid Tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
LY4101174 - Metastatic Solid Tumor, Recurrent Solid Tumor
Phase 1Active not recruitingEli Lilly and Company4902024-03-052026-05-22

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Ureteral Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)  ·  Urologic Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Adnexal Diseases (1)  ·  Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Squamous Cell (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Esophageal Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)

Sponsors

Eli Lilly and Company (1)

Countries

Australia (1)  ·  Belgium (1)  ·  China (1)  ·  France (1)  ·  Japan (1)  ·  Spain (1)  ·  United States (1)

NIH funding

2023 (1)